Le Lézard
Classified in: Health, Science and technology, Business
Subject: CXP

Digbi Health's Gut Biome and DNA-Based Weight Loss and Diabetes Management Program Launches with Blue Shield of California

MOUNTAIN VIEW, Calif., Nov. 25, 2019 /PRNewswire/ -- Digbi Health's clinically validated, personalized obesity, pre-diabetes and type 2 diabetes management program tailored to a person's DNA, gut biome, lifestyle preferences, and ethnicity is now available to Blue Shield of California members on the health plan's Wellvolution platform. A digital therapeutics and community health network that is the largest in the industry, Wellvolution was created in collaboration with Solera Health to help consumers holistically manage their health.

Gut microbiome and DNA-Based Weight Loss

Digbi Health's availability on the Wellvolution platform gives Blue Shield members access to a powerful, proven, DNA and gut microbiome-based precision care and personalized lifestyle medicine tool that is tailored to their unique biology and lifestyle.

"Doctors and payers understand that obesity and diabetes are multifactorial diseases, and one-size-fits-all diet and exercise weight loss and diabetes programs do not deliver patient engagement and sustained health results," said Ranjan Sinha, CEO, and founder of Digbi Health. "We are the first company to operationalize a DNA and gut microbiome-based prescription-grade platform for doctors and payers to deliver weight loss and diabetes programs at scale."

"Digbi Health is a strong fit for Wellvolution, which is designed to drive sustained engagement and outcomes by matching members to the program that best meets their needs," said Brenda Schmidt, CEO, Solera Health.

Blue Shield of California, an innovative health insurer with 4.3 million members, launched Wellvolution in June. The digital therapeutics platform, powered by Solera, features a selection of about 70 digital health apps (out of more than 300,000 currently available in the Apple App Store), curated for clinical effectiveness and consumer preference.

About Digbi Health
Digbi Health is a first-of-its-kind precision digital therapeutics (pDTx) company that offers a prescription-grade digitally delivered personalized obesity and diabetes management program based on an individual's gut biome, DNA, blood markers, and lifestyle factors. Digbi Health and members of its precision care MD network are committed to empowering people to take control of their own health and wellness. Digbi Health is prescribed by doctors, health care providers, and insurance companies. Digbi Health is currently conducting three Institutional Review Board approved human studies. Learn more at www.digbihealth.com. Or follow us on LinkedIn, Facebook or Twitter.


SOURCE Digbi Health

These press releases may also interest you

at 03:30
International Petroleum Corporation (IPC or the Corporation) is pleased to announce that IPC repurchased a total of 739,860 IPC common shares (ISIN: CA46016U1084) during the week of January 20 to 24, 2020 under the previously announced share...

at 03:09
Wego, the largest online travel marketplace in the Middle East and North Africa (MENA), has partnered with WebEngage to leverage omnichannel marketing automation to enhance its mobile app's user engagement. By partnering...

at 03:05
SpeakEasy Cannabis Club Ltd.  (the "Company" or "SpeakEasy"), a holder of a federal licence to cultivate, process and sell cannabis under the Cannabis Act, is pleased to announce that it has signed a non-binding letter of intent with M&J Orchards...

at 03:00
Vade Secure, the global leader in predictive email defense, today announced the appointment of Frédéric Braut, Senior Vice President EMEA. A recognized leader in the IT ecosystem (infrastructure, network, security and cloud), Braut was previously...

at 03:00
CustomerGauge, creator of the Account Experiencetm category maximizing retention and growth for B2B companies, today announced it has closed a funding round with Riverside Acceleration Capital (RAC). The funding will continue to fuel CustomerGauge's...

at 03:00
A global leader in online multi-asset trading services and currency data and analytics, OANDA is pleased to announce the appointment of Emmanuel Coulon as Chief Technology Officer. He will be responsible for driving the firm's global technology...

News published on 25 november 2019 at 09:04 and distributed by: